Zentalis Pharmaceuticals, LLC Business Finance Contracts & Agreements
14 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Release Agreements (4)
- Stock Agreements (4)
- Underwriting Agreements (5)
- Underwriting Agreement, dated June 1 (Filed With SEC on June 15, 2023)
- Release Agreement, dated September 23, 2022. between Zentalis Pharmaceuticals, Inc. and Dimitris Voliotis (Filed With SEC on November 9, 2022)
- Underwriting Agreement, dated May 16, 2022, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB (Filed With SEC on May 16, 2022)
- Release Agreement, dated May 10, 2022, between Zentalis Pharmaceuticals, Inc. and Anthony Y. Sun, M.D (Filed With SEC on May 16, 2022)
- Underwriting Agreement, dated June 28, 2021, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB Leerink LLC, as representatives of the several... (Filed With SEC on July 1, 2021)
- Description of Capital Stock (Filed With SEC on March 25, 2021)
- Release Agreement by and between Zeno Management, Inc. and Robert Winkler, M.D (Filed With SEC on July 27, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 27, 2020)
- Release Agreement, dated May (Filed With SEC on May 15, 2020)
- Form of Underwriting Agreement (Filed With SEC on March 30, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on March 30, 2020)
- Form of Conversion Restricted Stock Award Agreement for former Class B Common Unit Holders (Filed With SEC on March 30, 2020)
- Amended and Restated Investors Rights Agreement, dated as of September 6, 2019, by and among Zentalis Pharmaceuticals, LLC and the investors party thereto (Filed With SEC on March 6, 2020)
- Specimen Common Stock Certificate evidencing the shares of common stock (Filed With SEC on March 6, 2020)
